Evidence map›Paper›PMID 33009905›Full record

Trial reportJournal of psychiatry & neuroscience : JPN2021

Confidence in visual motion discrimination is preserved in individuals with schizophrenia.

Nathan Faivre, Matthieu Roger, Michael Pereira, Vincent de Gardelle, Jean-Christophe Vergnaud, Christine Passerieux, Paul Roux

Open access · diamondAbstract readClinical Trial
In one paragraph

Trial report in Journal of psychiatry & neuroscience : JPN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Nathan FaivreFrom the Université Grenoble Alpes, Grenoble, France (Faivre, Pereira); the Centre d'Economie de la Sorbonne, Paris, France (Faivre, de Gardelle, Vergnaud); the Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, INSERM UMR1018, Centre de recherche en Épidémiologie et Santé des Populations, Equipe DevPsy, Villejuif, France (Roger, Passerieux, Roux); the Centre Hospitalier de Versailles, Service Hospitalo-Universitaire de psychiatrie d'adultes et d'addictologie, Le Chesnay, France (Roger, Passerieux, Roux); and the Fondation Fondamental, Créteil, France (Passerieux, Roux).
Matthieu RogerFrom the Université Grenoble Alpes, Grenoble, France (Faivre, Pereira); the Centre d'Economie de la Sorbonne, Paris, France (Faivre, de Gardelle, Vergnaud); the Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, INSERM UMR1018, Centre de recherche en Épidémiologie et Santé des Populations, Equipe DevPsy, Villejuif, France (Roger, Passerieux, Roux); the Centre Hospitalier de Versailles, Service Hospitalo-Universitaire de psychiatrie d'adultes et d'addictologie, Le Chesnay, France (Roger, Passerieux, Roux); and the Fondation Fondamental, Créteil, France (Passerieux, Roux).
Michael PereiraFrom the Université Grenoble Alpes, Grenoble, France (Faivre, Pereira); the Centre d'Economie de la Sorbonne, Paris, France (Faivre, de Gardelle, Vergnaud); the Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, INSERM UMR1018, Centre de recherche en Épidémiologie et Santé des Populations, Equipe DevPsy, Villejuif, France (Roger, Passerieux, Roux); the Centre Hospitalier de Versailles, Service Hospitalo-Universitaire de psychiatrie d'adultes et d'addictologie, Le Chesnay, France (Roger, Passerieux, Roux); and the Fondation Fondamental, Créteil, France (Passerieux, Roux).
Vincent de GardelleFrom the Université Grenoble Alpes, Grenoble, France (Faivre, Pereira); the Centre d'Economie de la Sorbonne, Paris, France (Faivre, de Gardelle, Vergnaud); the Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, INSERM UMR1018, Centre de recherche en Épidémiologie et Santé des Populations, Equipe DevPsy, Villejuif, France (Roger, Passerieux, Roux); the Centre Hospitalier de Versailles, Service Hospitalo-Universitaire de psychiatrie d'adultes et d'addictologie, Le Chesnay, France (Roger, Passerieux, Roux); and the Fondation Fondamental, Créteil, France (Passerieux, Roux).
Jean-Christophe VergnaudFrom the Université Grenoble Alpes, Grenoble, France (Faivre, Pereira); the Centre d'Economie de la Sorbonne, Paris, France (Faivre, de Gardelle, Vergnaud); the Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, INSERM UMR1018, Centre de recherche en Épidémiologie et Santé des Populations, Equipe DevPsy, Villejuif, France (Roger, Passerieux, Roux); the Centre Hospitalier de Versailles, Service Hospitalo-Universitaire de psychiatrie d'adultes et d'addictologie, Le Chesnay, France (Roger, Passerieux, Roux); and the Fondation Fondamental, Créteil, France (Passerieux, Roux).
Christine PasserieuxFrom the Université Grenoble Alpes, Grenoble, France (Faivre, Pereira); the Centre d'Economie de la Sorbonne, Paris, France (Faivre, de Gardelle, Vergnaud); the Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, INSERM UMR1018, Centre de recherche en Épidémiologie et Santé des Populations, Equipe DevPsy, Villejuif, France (Roger, Passerieux, Roux); the Centre Hospitalier de Versailles, Service Hospitalo-Universitaire de psychiatrie d'adultes et d'addictologie, Le Chesnay, France (Roger, Passerieux, Roux); and the Fondation Fondamental, Créteil, France (Passerieux, Roux).
Paul RouxFrom the Université Grenoble Alpes, Grenoble, France (Faivre, Pereira); the Centre d'Economie de la Sorbonne, Paris, France (Faivre, de Gardelle, Vergnaud); the Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, INSERM UMR1018, Centre de recherche en Épidémiologie et Santé des Populations, Equipe DevPsy, Villejuif, France (Roger, Passerieux, Roux); the Centre Hospitalier de Versailles, Service Hospitalo-Universitaire de psychiatrie d'adultes et d'addictologie, Le Chesnay, France (Roger, Passerieux, Roux); and the Fondation Fondamental, Créteil, France (Passerieux, Roux).
Inserm · FRUniversité Grenoble Alpes · FRCentre d'Économie de la Sorbonne · FRCentre Hospitalier de Versailles · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetacognition is the set of reflexive processes that allows humans to evaluate the accuracy of their mental operations. Metacognitive deficits have been described in people with schizophrenia using mostly narrative assessment, and they have been linked to several key symptoms.

methodsWe assessed metacognitive performance objectively by asking people with schizophrenia or schizoaffective disorder (

resultsBayesian analyses revealed equivalent metacognitive performance in the 2 groups, despite a weaker association between confidence and trajectory tracking during task execution among people with schizophrenia. We reproduced these results using an evidence accumulation model, which showed similar decisional processes in the 2 groups. LIMITATIONS: These results from a relatively small study sample cannot be generalized to other perceptual and nonperceptual tasks. To meet this purpose, ecological tasks are needed. As well, the role of antipsychotic medication and design deserves greater attention in the future.

conclusionWe found similar decisional and metacognitive capabilities between people with schizophrenia and healthy controls in a visual discrimination task.

Indexed as

AdultDiscrimination, PsychologicalFemaleHumansMaleMetacognitionMiddle AgedMotion PerceptionPattern Recognition, VisualPsychotic DisordersSchizophrenia

Identifiers

PMID33009905
PMCPMC7955841
OpenAlexW3090793875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.